DeepValue | The New Way Investors Work

Pagaya Technologies Ltd. (NASDAQ: PGY) sits at the intersection of AI underwriting and old-school capital markets. On the surface, it looks like a high-growth, next‑gen fintech story: proprietary models, strong partner volume, and a steady cadence of asset‑backed securities (ABS) deals. Underneath, though, the stock is tied to something much more traditional and unforgiving: funding spreads, risk retention requirements, and credit provisioning.

From our perspective at DeepValue, this is exactly the kind of name where disciplined investors can gain an edge. The narrative right now is noisy—“AI lending platform,” “capital‑markets machine,” “revolving ABS innovation”—but the equity value will rise or fall on a handful of very specific, measurable drivers. That’s why our current rating on PGY is WAIT, with higher conviction only if we see one quarter of hard evidence that funding is not just available, but profitable.

Before digging in, here’s the core setup: at $11.34 per share, the stock already bakes in management’s 2026 targets for $410M–$460M in adjusted EBITDA and $100M–$150M in GAAP net income, according to the latest 10-K (2026) and guidance commentary. Yet 2025 ended with negative capital markets execution fees—about -$6M in Q4 and -$21M for the full year—signaling that ABS deal economics are under pressure despite continued issuance, as highlighted in the 2025 earnings call transcript (Feb 9 2026).

That tension between volume and economics is the heart of the story.

If you want to see how we systematize this kind of deep fundamental work, we actually run the same structured process across hundreds of names using DeepValue. It ingests 10‑Ks, 10‑Qs, 8‑Ks, and niche industry sources automatically, so you can turn what used to be hours of 10‑K reading into minutes of high‑signal analysis.

Use our deep research engine to replicate this kind of ABS, credit, and capital-structure breakdown across PGY and its peers in minutes, not days.

Run Deep Research on PGY →

Pagaya’s Business Model: AI Lending Meets Capital Markets Reality

Pagaya’s model is deceptively simple on paper, and more complex in practice.

The company generates revenue primarily based on Network Volume—the dollar amount of assets that its AI technology identifies and routes into its Financing Vehicles for acquisition and funding, as described in the 10-Q (2025). Those vehicles are then financed via ABS and other institutional arrangements.

Key mechanics that matter for equity holders:

Pagaya sponsors unconsolidated securitization VIEs and must retain at least 5% of the credit risk of those securities, per the 10-K (2026), Off‑Balance Sheet Arrangements.
It recognizes gains, fees, and fair‑value marks tied to these assets, with investments in loans and securities valued via discounted cash-flow models that “require significant judgment,” according to the 10-K (2026), Fair Value.
Network Volume itself is growing nicely: $2.8B for the three months ended September 30, 2025 vs. $2.35B a year earlier, and $7.85B for the nine months vs. $7.10B, per the 10-Q (2025).

So far, so good. Partners are sending more flow, and Pagaya is routing more loans into its network. But investors are not paying up just for volume. They’re paying for unit economics: funding costs, credit performance, and the spread between what institutional investors demand and what Pagaya can charge.

Management itself has drawn a straight line between ABS pricing and earnings. On the Q4 2025 call, they framed it bluntly: a 100 basis point discount in ABS pricing equates to roughly $10M less in upfront fees, as detailed in the earnings call transcript (Feb 9 2026). That sensitivity means funding spreads, not volume, are the real P&L swing factor.

Why We Rate PGY a “WAIT” Today

Our internal rating on Pagaya is WAIT, with a conviction score of 3.5/5. That’s not a bearish call so much as a statement that the risk/reward looks better if you demand proof before buying.

Here’s our valuation framework from the report:

Base case (50% probability)

Implied value: $13
Assumes revolving ABS and forward-flow commitments absorb a meaningful portion of loan flow, smoothing issuance volatility.
Adjusted EBITDA: $410M–$460M with adequate liquidity to support 5% risk retention.

Bear case (30% probability)

Implied value: $7
AAA consumer ABS spreads widen by 100+ bps vs recent deals.
Adjusted EBITDA falls below $350M as upfront fees compress and credit reserves build again.

Bull case (20% probability)

Implied value: $18
Investor breadth strengthens, with repeated ABS upsizes and 30+ investors per deal.
GAAP net income reaches $150M, execution fees turn positive, and provisions stabilize.

At $11.34, the stock is trading between our base and bear outcomes. On our numbers, that’s not a compelling margin of safety when:

Capital markets execution fees are already negative, per the earnings call highlights (Feb 11 2026).
Credit reserves have stepped up sharply, including a one‑time allowance for credit losses addition of 112,263 and an ending allowance balance of (252,934), as disclosed in the 10-Q (2025), p. 17.
The company itself warns that a small number of funding sources drive a large share of investment revenue, and those sources “may be unwilling or unable to provide funding… on terms acceptable… or at all,” in the 8-K (2026).

Our takeaway: the business‑model margin of safety is thin. Downside is dominated by funding terms and credit marks rather than hard assets or recurring, low‑volatility cash flows.

What would change our call?

We explicitly laid out two conditions that would strengthen our rating:

1. Positive capital markets execution fees in the next quarterly filing, showing that ABS clearing levels have moved back in Pagaya’s favor.

2. Stable allowance for credit losses, with no repeat of the step‑change increase seen in the September 2025 quarter.

If both conditions are met while ABS investor breadth remains strong, we’d reassess toward the $13–$18 value range with higher conviction.

Is PGY Stock a Buy in 2026?

From a pure DCF-style perspective, you could argue that if management hits its 2026 targets, today’s price is reasonable to slightly cheap. But that framing glosses over the distribution of outcomes.

We think of PGY more like a capital‑markets‑sensitive credit platform than a typical SaaS or software-enabled fintech. That means the key question is not, “Will revenue grow?” but rather:

Can Pagaya issue ABS consistently?
At what spreads and fee levels?
With what credit performance on the retained risk?

The market narrative today, as synthesized from recent coverage, is that Pagaya is a “repeat issuer” and capital-markets machine in consumer‑credit ABS. Articles have highlighted the company’s cadence and scale of issuance, particularly the $2.9B across seven ABS transactions in Q4 2025 and the early‑2026 PAID 2026‑1 deal upsized to $800M AAA from $600M with 32 unique investors, per Pagaya’s Business Wire release (Feb 4 2026) and Defense World’s earnings highlights (Feb 11 2026).

That breadth and upsizing are real positives. They tell us:

Investor demand is still there.
Pagaya has not been shut out of the ABS market.
The company can potentially lean on that access to stabilize funding.

But the same sources—and Pagaya’s own commentary—consistently flag spread sensitivity and “pricing tension.” Investing.com coverage from November 2025 noted that Pagaya had to raise a $399M bond at higher yields than expected, reflecting investor scrutiny and a higher cost of debt. Management has been clear that ABS pricing directly feeds into fee compression.

For us, that blend of strong access but pressured economics puts PGY squarely in the “prove it” bucket for 2026. We don’t need multiple years of data to get more constructive—but we do need at least one clean quarter where:

Execution fees flip positive.
Reserves look stable.
The ABS investor roster still looks broad (30+ accounts on flagship deals).

If you’re building or updating your own watchlist of “prove it” names, this is exactly where tools like DeepValue fit in. You can queue up 10+ tickers—PGY, its ABS‑exposed peers, and some deposit‑funded comparables—and get standardized, citation‑rich reports in about five minutes.

Quickly compare PGY’s funding risks, credit trends, and guidance assumptions against a basket of fintech and lending peers using automated deep-dive reports.

Research PGY in Minutes →

Will Pagaya Deliver Long-Term Growth?

The long‑term story for Pagaya hinges on whether it can turn today’s AI underwriting pitch and ABS execution into something structurally durable:

1. Funding durability

The roadmap is to shift from episodic, “print‑and‑pray” ABS windows toward replenishable and committed capital:

A $350M revolving personal-loan ABS (PAID 2025‑REV1) with a 24‑month revolving period, positioned as up to ~$700M of capacity, per StreetInsider (Jan 16 2026).
Forward‑flow commitments including up to $720M in POS loans with Sound Point and up to $500M in auto loans with Castlelake, per Pagaya’s POS funding announcement (Jan 26 2026) and Business Wire’s Castlelake agreement release (Nov 3 2025).

The question isn’t whether these structures exist—they do. The question is utilization. Over the next 6–18 months, we’ll be looking for tangible evidence that these revolving and forward‑flow channels are actually absorbing volume and replenishing as intended, not just providing headline capacity.

2. Capital intensity and risk retention

Pagaya must retain ~5% capital per $1B of ABS issuance, which management translates into about $50M of capital tied up for each $1B funded, per the earnings call transcript (Feb 9 2026). That’s a structural drag compared to deposit‑funded or better‑capitalized competitors.

To partially offset this, Pagaya:

Expanded its corporate revolving credit facility from $58M to $132M while reducing pricing from SOFR+750 to SOFR+350, as disclosed in the 8‑K filing (Oct 2 2025) on SECDatabase.

But the underlying reality stands: as issuance scales, so does the capital burden of risk retention. That can cap growth or push management toward equity dilution if internal capital generation lags.

3. Credit performance

The one‑time 112,263 addition to allowance for credit losses and the ending allowance balance of (252,934) reported in the 10-Q (2025), p. 17 are not trivial. They signal that:

Underwriting models are being tested by the current macro and consumer credit cycle.
ABS investors will demand evidence of stable or improving losses before tightening spreads.

For long‑term holders, we think stable or declining reserve ratios over the next several quarters are at least as important as volume growth. Without that, Pagaya’s AI moat is more aspirational than realized.

Put simply, yes, Pagaya can deliver long‑term growth—if these funding and credit pieces fall into place. But those conditions are stringent, and they’re exactly why we’re not rushing to buy at current levels.

Margin of Safety (Or Lack Thereof)

We rarely see a true asset‑backed margin of safety in a company whose results are so intertwined with fair‑value marks, ABS spread dynamics, and discretionary capital from institutional investors.

In Pagaya’s own disclosures:

Funding is concentrated in a small number of sources, which could refuse or reprice capital, according to the 8-K (2026).
At least 5% of credit risk must be retained on sponsored securitizations, as set out in the 10-K (2026), Off‑Balance Sheet Arrangements.
Valuation of loans and securities relies on discounted cash‑flow models that require significant judgment, per the 10-K (2026), Fair Value.

From an equity perspective, this means that if:

1. ABS pricing moves materially against Pagaya, keeping execution fees negative and compressing upfront fees (remember the 100 bps = $10M mapping); and

2. Credit reserve builds accelerate beyond recent levels,

then capital impairment is no longer a tail risk but a base‑rate scenario. That’s the structural reason we size PGY as a small, high‑beta position only after evidence of improved execution—not a core holding.

Key Catalysts and Monitoring Checklist

We think investors should treat Pagaya like a checklist stock: own it when the boxes are ticked, step aside when they aren’t. From our report, here are the concrete items we’re watching:

Next 90 days (through roughly June 2026)

By around 2026‑06‑01:

ABS follow‑through

If no additional ABS deals are announced or disclosed with breadth and size comparable to PAID 2026‑1 ($800M AAA, 32 investors), the thesis that capital markets access is durable weakens. That’s a signal to reduce exposure, as flagged in Pagaya’s ABS announcement (Feb 4 2026).

Capital markets execution fees

If the next earnings update again reports negative execution fees, we treat that as clear economics deterioration. Without quantified offsets (better partner terms, improved pricing, or cost actions), our base reaction would be to avoid or exit, per the earnings call highlights (Feb 11 2026).

Allowance for credit losses

Another large step‑up in the allowance above the already material one‑time addition and ending balance would indicate spreading credit pressure. That would merit a more cautious stance until loss trends visibly stabilize, per the 10-Q (2025), p. 17.

90–180 days (through roughly August 2026)

By around 2026‑08‑31:

Revolving and forward‑flow utilization

If we still haven’t seen clear evidence that the revolving ABS (PAID 2025‑REV1) and forward‑flow facilities (Sound Point POS, Castlelake auto) are being actively utilized and replenished, the thesis that funding is becoming more durable fails. That would push us to treat Pagaya as an ABS‑only funding story again, based on StreetInsider’s revolving ABS coverage (Jan 16 2026) and the Sound Point agreement release (Jan 26 2026).

Positive scenario trigger

Conversely, if ABS prints continue to upsize with broad participation and execution fees have turned positive, while reserves stay stable and on‑balance exposure doesn’t creep higher via purchases from Financing Vehicles, we’d see that as a green light to add. This is the scenario where our $13–$18 range looks realistic.

This kind of explicit, time‑bound monitoring is where AI tools really shine. Instead of manually scanning each new 10‑Q or ABS press release, you can have DeepValue surface exactly when those conditions flip—positive or negative.

Track these ABS, credit, and funding checklists automatically across your watchlist using DeepValue’s parallel deep research engine.

See the Full Analysis →

Competitive Positioning and AI “Moat” Reality

Pagaya presents itself as an AI‑driven lending network that helps partners originate more loans with better risk‑adjusted performance. In the 10-Q (2025), management explicitly ties Network Volume growth to improvements in proprietary technology and partner relationships.

Evidence of real edge:

Network Volume growth in both three‑ and nine‑month periods year over year.
The ability to place and upsize a flagship ABS deal (PAID 2026‑1) to $800M AAA with 32 unique investors, as reported in Pagaya’s Feb 4 2026 release.
Ongoing expansion into POS and auto programs via new partners and forward‑flow agreements.

Evidence of limits:

Negative capital markets execution fees in Q4 and full‑year 2025, highlighted in Defense World’s Q4 earnings summary (Feb 11 2026), show that Pagaya does not yet command pricing power over its cost of capital.
Structural weaknesses vs. better‑capitalized or deposit‑funded peers:
Concentrated funding sources for investment revenue, per the 8-K (2026).
Mandatory 5% risk retention, which consumes capital as issuance scales, per the 10-K (2026), Off‑Balance Sheet Arrangements.

Relative to names like Upstart, Affirm, and consumer lenders with deposits (SoFi, LendingClub, Enova), Pagaya’s relative strengths are:

A clear track record of ABS issuance through volatile markets (e.g., $2.9B across seven ABS transactions in Q4 2025, as referenced in Defense World’s earnings highlights (Feb 11 2026)).
An increasingly diversified partner base across personal loans, POS, and auto.

Its relative handicaps are:

Higher capital intensity due to risk retention.
Reliance on wholesale funding rather than deposits.
Greater sensitivity of earnings to ABS pricing and credit marks.

We don’t see a bulletproof moat yet. We see a promising AI platform that still has to earn durable economics through several more credit and capital markets cycles.

Management, Governance, and Alignment

On stewardship, our view is cautiously constructive but not glowing.

Positives:

Pagaya navigated a choppy funding environment marked by elevated risk‑free rates and external shocks like isolated bank failures/downgrades in 2024, as outlined in the 10-K (2026).
The company has continued to grow Network Volume despite this backdrop.
Governance maturity improved as Pagaya became a large accelerated filer, bringing auditor evaluation of internal control over financial reporting into the 2025 Form 10‑K, also detailed in the 10-K (2026).
The corporate revolver recap (larger facility, much lower spread) is a sensible, shareholder‑friendly move, per the Oct 2 2025 8‑K excerpt.

Offsets:

Reported performance is quite sensitive to fair‑value marks where management judgment matters, as flagged in the 10-K (2026), Fair Value. That increases the premium we place on conservative disclosure and transparency.
Insider trading patterns look mostly like standard RSU/option exercises and routine sales, with no notable red or green flags in the dataset we reviewed. They neither strengthen nor undermine our conviction materially.

On balance, we view management as capable operators but still proving themselves as capital allocators in a high‑leverage, spread‑sensitive model.

Our Bottom Line on PGY

Putting it all together:

Pagaya is an AI‑enhanced lending network, not a pure software business. Its economics are deeply tied to ABS funding spreads, risk retention, and credit provisioning.
The stock price already embeds management’s 2026 profitability targets but does not offer a clear margin of safety given:
Negative execution fees.
Rising allowances for credit losses.
Structural capital intensity from risk retention.

Our stance as the DeepValue team is:

Rating: WAIT
Trim above: $16
Attractive entry range: closer to $10, contingent on improved execution and credit signals.
Re‑assessment window: 3–6 months, keyed to the next one or two quarterly filings and ABS deal updates.

If, over that window, Pagaya can deliver:

Positive capital markets execution fees.
Stable or improving allowances for credit losses.
Continued breadth and upsizing in ABS deals, plus visible utilization of revolving and forward‑flow programs.

Then we’d be comfortable upgrading our view and leaning toward the $13–$18 value range with higher conviction. If instead spreads stay wide, execution fees remain negative, and reserves step up again, we see a credible path to $7.

For now, we think disciplined investors are better served by watching closely rather than rushing in.

If you’d like to apply this sort of structured, citation‑backed process across your entire portfolio, our team built a guide that shows exactly how we use AI to do it at scale: Read our AI-powered value investing guide. It walks through how tools like DeepValue can parse SEC filings, scan niche industry sources, and surface the key drivers—so you can spend more time on judgment and less on document slog.

Put this PGY framework on autopilot by having DeepValue watch ABS, credit, and funding disclosures across all your holdings and watchlist names.

Try DeepValue Free →

Pagaya Technologies Ltd. (PGY) Deep Research Report: Funding Costs vs. AI Ambition – What 2026 Investors Need to See First